Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress

Published:2013-05-07 Issue:9 Volume:15 Page:1186-1199
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Suzuki Kenshi,Gerelchuluun Ariungerel,Hong Zhengshan,Sun Lue,Zenkoh Junko,Moritake Takashi,Tsuboi Koji

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/15/9/1186/16859636/not062.pdf

Reference63 articles.

1. Primary and secondary glioblastomas: from concept to clinical diagnosis;Kleihues;Neuro-Oncology,1999

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;The New England Journal of Medicine,2005

3. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;The New England Journal of Medicine,2005

4. An integrated genomic analysis of human glioblastoma multiforme;Parsons;Science,2008

5. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes;Lo;Molecular Cancer Research: MCR,2010

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier;Journal of Drug Delivery Science and Technology;2024-09

2. Modern view on the effectiveness and safety of non-steroidal anti-inflammatory drugs;Reviews on Clinical Pharmacology and Drug Therapy;2024-07-22

3. The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target;CNS Neuroscience & Therapeutics;2024-07

4. Understanding the Significance of Hypoxia-Inducible Factors (HIFs) in Glioblastoma: A Systematic Review;Cancers;2024-05-30

5. Endoplasmic Reticulum Stress in Gliomas: Exploiting a Dual-Effect Dysfunction through Chemical Pharmaceutical Compounds and Natural Derivatives for Therapeutical Uses;International Journal of Molecular Sciences;2024-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3